72.11.Z - Scientific research and development activities
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
72.19.Z - Scientific research and development activities
74.10.Z - Specialized design activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
85.60.Z - Educational support activities
86.90.E - Healthcare
2019 | 2020 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | -1,6 | -1,9 | -17,6 |
EBITDA | 0,1 | -1,6 | -1629 |
Short time liabilities | 0 | 1 | -∞ |
Equity capital | 0,9 | 7,8 | 727,4 |
Operating profit (EBIT) | 0 | -1,8 | ∞ |
Assets | 2,2 | 9,6 | 338 |
Net profit (loss) | -1,6 | -1,7 | -4,3 |
Cash | 0 | 7,3 | -∞ |
Net income from sale | 0,2 | 0 | -86,7 |
Liabilities and provisions for liabilities | 1,3 | 1,8 | 45,6 |
Working assets | 1,8 | 7,9 | 348,6 |
Depreciation | 0,1 | 0,2 | 134,7 |
% | % | p.p. | |
Profitability of capital | -172 | -21,7 | 150,3 |
Equity capital to total assets | 42,9 | 81 | 38,1 |
Gross profit margin | -1060,3 | -9355,7 | -8295,4 |
EBITDA Margin | 68 | -7809,2 | -7877,2 |
Days | Days | Days | |
Short term commitment turnover cycle | 0 | 17 418 | 17 418 |
Current financial liquidity indicator | 6.572581768035889 | ||
Net dept to EBITDA | 0 | 3.944079637527466 | 3,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane